Pictet Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.8M | Sell |
595,681
-69,889
| -11% | -$1.03M | 0.01% | 681 |
|
|
2025
Q1 | $13.1M | Sell |
665,570
-43,820
| -6% | -$861K | 0.01% | 594 |
|
|
2024
Q4 | $12.4M | Sell |
709,390
-53,518
| -7% | -$932K | 0.01% | 607 |
|
|
2024
Q3 | $10.7M | Sell |
762,908
-215,046
| -22% | -$3.01M | 0.01% | 633 |
|
|
2024
Q2 | $8.04M | Sell |
977,954
-1,260,914
| -56% | -$10.4M | 0.01% | 677 |
|
|
2024
Q1 | $17.2M | Sell |
2,238,868
-128,010
| -5% | -$984K | 0.02% | 522 |
|
|
2023
Q4 | $21.3M | Buy |
2,366,878
+226,338
| +11% | +$2.03M | 0.02% | 477 |
|
|
2023
Q3 | $19.1M | Buy |
+2,140,540
| New | +$19.1M | 0.02% | 468 |
|